Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Evan Lippman
17 Aug 2026
EVP, Business Development
Sold on a plan
18,600
$36.57
$680.29K
Eliyahu Sharon Kalif
11 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
106,563
$34.10
$3.63M
Eliyahu Sharon Kalif
14 May 2026
EVP, Chief Financial Officer
Sold on a plan
153,251
$35.61
$5.46M
Eliyahu Sharon Kalif
26 Feb 2026
EVP, Chief Financial Officer
Sold on a plan
345,810
$33.64
$11.63M
Eliyahu Sharon Kalif
12 Jun 2025
EVP, Chief Financial Officer
Sold on a plan
55,775
$17.08
$952.46K
Richard D Francis
5 Mar 2025
President and CEO
Sold on a plan
8,259
$15.91
$131.43K
Richard Daniell
5 Mar 2025
Exec. VP, European Commercial
Sold on a plan
30,015
$15.91
$477.63K
Richard Daniell
5 Mar 2025
Exec. VP, European Commercial
Sold on a plan
7,108
$15.91
$113.11K
Richard Daniell
5 Mar 2025
Exec. VP, European Commercial
Sold on a plan
11,641
$15.91
$185.25K
Eric A Hughes
5 Mar 2025
See "Remarks"
Sold on a plan
8,077
$15.91
$128.53K
David R. McAvoy
5 Mar 2025
EVP, Chief Legal Officer
Sold on a plan
1,677
$15.91
$26.69K
Christine Fox
5 Mar 2025
EVP, Head of U.S. Commercial
Sold on a plan
2,147
$15.91
$34.17K
Richard D Francis
4 Mar 2025
President and CEO
Sold on a plan
6,450
$15.56
$100.35K
Eric A Hughes
4 Mar 2025
See "Remarks"
Sold on a plan
5,174
$15.56
$80.50K
Richard Daniell
4 Mar 2025
Exec. VP, European Commercial
Sold on a plan
12,936
$15.56
$201.25K
Eliyahu Sharon Kalif
28 Feb 2025
EVP, Chief Financial Officer
Sold on a plan
55,750
$16.21
$903.46K
Richard D Francis
18 Feb 2025
President and CEO
Sold on a plan
75,506
$16.95
$1.28M
Eliyahu Sharon Kalif
6 Mar 2024
EVP, Chief Financial Officer
Sold on a plan
77,550
$13.52
$1.05M
Eric A Hughes
4 Mar 2024
See "Remarks"
Sold on a plan
8,045
$13.34
$107.30K
Richard D Francis
4 Mar 2024
President and CEO
Sold on a plan
31,061
$13.34
$414.27K
Showing 250 of 313 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 596
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 180
Sales at will 107
Transactions with no price 0
Shares from compensation/vesting 11,881,795
Sales filed before the plan box existed 79
History held since 24 Jul 2008